These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26996725)

  • 21. Congenital cytomegalovirus infection and hearing loss.
    Pass RF
    Herpes; 2005 Oct; 12(2):50-5. PubMed ID: 16209862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged KI polyomavirus infection in immunodeficient child.
    Falcone V; Panning M; Strahm B; Vraetz T; Bierbaum S; Neumann-Haefelin D; Huzly D
    Emerg Infect Dis; 2012 Apr; 18(4):706-8. PubMed ID: 22469436
    [No Abstract]   [Full Text] [Related]  

  • 23. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus.
    Germi R; Mariette C; Alain S; Lupo J; Thiebaut A; Brion JP; Epaulard O; Saint Raymond C; Malvezzi P; Morand P
    Antiviral Res; 2014 Jan; 101():57-61. PubMed ID: 24184983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
    Almyroudis NG; Jakubowski A; Jaffe D; Sepkowitz K; Pamer E; O'Reilly RJ; Papanicolaou GA
    Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet.
    Hubacek P; Keslova P; Formankova R; Pochop P; Cinek O; Zajac M; Lochmanova J; Stary J; Sedlacek P
    Pediatr Transplant; 2009 Nov; 13(7):919-22. PubMed ID: 19067913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of breast-feeding in cytomegalovirus transmission and hematopoietic stem cell transplant outcomes in infants with severe combined immunodeficiency.
    Kelty WJ; Beatty SA; Wu S; Hanson IC; Demmler-Harrison GJ; Martinez CA; Orange JS; Davis CM
    J Allergy Clin Immunol Pract; 2019; 7(8):2863-2865.e3. PubMed ID: 31326381
    [No Abstract]   [Full Text] [Related]  

  • 28. Gut microbiome variations during hematopoietic stem cell transplant in severe combined immunodeficiency.
    Lane JP; Stewart CJ; Cummings SP; Gennery AR
    J Allergy Clin Immunol; 2015 Jun; 135(6):1654-6. PubMed ID: 25769913
    [No Abstract]   [Full Text] [Related]  

  • 29. Postencephalitic epilepsy secondary to cytomegalovirus encephalitis.
    Nasuno M; Shigemura T; Nakazawa Y; Inaba Y; Motobayashi M
    Pediatr Int; 2018 Aug; 60(8):758-760. PubMed ID: 30058130
    [No Abstract]   [Full Text] [Related]  

  • 30. Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients.
    Ruiz-Camps I; Len O; de la Cámara R; Gurguí M; Martino R; Jarque I; Barrenetxea C; Díaz de Heredia C; Batlle M; Rovira M; de la Torre J; Torres A; Aguilar M; Espigado I; Martín-Dávila P; Bou G; Borrell N; Aguado JM; Pahissa A;
    Antivir Ther; 2011; 16(7):951-7. PubMed ID: 22024510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenal insufficiency associated with cytomegalovirus infection in two infants.
    Dinleyici EC; Dogruel N; Dinleyici M; Us T
    Int J Infect Dis; 2009 Jul; 13(4):e181-4. PubMed ID: 19062324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?
    Kekre N; Tokessy M; Mallick R; McDiarmid S; Huebsch L; Bredeson C; Allan D; Tay J; Tinmouth A; Sheppard D
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1719-24. PubMed ID: 24099958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Timing of CMV-specific effector memory T cells predicts viral replication and survival after allogeneic hematopoietic stem cell transplantation.
    Espigado I; de la Cruz-Vicente F; BenMarzouk-Hidalgo OJ; Gracia-Ahufinger I; Garcia-Lozano JR; Aguilar-Guisado M; Cisneros JM; Urbano-Ispizua A; Perez-Romero P
    Transpl Int; 2014 Dec; 27(12):1253-62. PubMed ID: 25070273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamics of cytomegalovirus (CMV) plasma DNAemia in initial and recurrent episodes of active CMV infection in the allogeneic stem cell transplantation setting: implications for designing preemptive antiviral therapy strategies.
    Muñoz-Cobo B; Solano C; Costa E; Bravo D; Clari MÁ; Benet I; Remigia MJ; Montoro J; Navarro D
    Biol Blood Marrow Transplant; 2011 Nov; 17(11):1602-11. PubMed ID: 21871245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytomegalovirus infection in pediatric allogenic hematopoietic stem cell transplantation. A single center experience.
    Sedky M; Mekki Y; Mialou V; Bleyzac N; Girard S; Salama E; Abdel Rahman H; Bertrand Y
    Pediatr Hematol Oncol; 2014 Nov; 31(8):743-53. PubMed ID: 24308761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe cutaneous papillomavirus disease after haematopoietic stem-cell transplantation in patients with severe combined immunodeficiency.
    Gaspar HB; Harwood C; Leigh I; Thrasher AJ
    Br J Haematol; 2004 Oct; 127(2):232-3. PubMed ID: 15461635
    [No Abstract]   [Full Text] [Related]  

  • 37. Severe combined immunodeficiency with abnormalities in expression of the common leucocyte antigen, CD45.
    Cale CM; Klein NJ; Novelli V; Veys P; Jones AM; Morgan G
    Arch Dis Child; 1997 Feb; 76(2):163-4. PubMed ID: 9068311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytomegalovirus in immunocompromised children.
    Vora SB; Englund JA
    Curr Opin Infect Dis; 2015 Aug; 28(4):323-9. PubMed ID: 26098503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Surveillance of cytomegalovirus for antiviral efficacy and risk factors in allogeneic hematopoietic stem cell transplantation].
    Jia JS; Liu DP; Huang XJ; Wu T; Liu DH; Zhang YC; Su H; Wang JB; Zhou JR; Liu Q; Ying MY; Sun RJ; Duan X; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):749-54. PubMed ID: 16928314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus prophylaxis and treatment following bone marrow transplantation.
    Tsinontides AC; Bechtel TP
    Ann Pharmacother; 1996 Nov; 30(11):1277-90. PubMed ID: 8913411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.